August 12, 2025

NHS to fast-track patients with head and neck cancer

The investigational cancer vaccine uses mRNA technology to help the immune system recognise and kill cancer cells containing human papillomavirus proteins.

More than 100 patients with advanced head and neck cancer in England will be matched to the trial, running at 15 NHS hospitals over the next year, supported by the NHS’ Cancer Vaccine Launch Pad (CVLP).

Read more – NHSE (8/8/25)

Leave a Reply

Your email address will not be published. Required fields are marked *